The DOI matches its Crossref record; 62 of the 64 references it cites were found in a registry or an index.
Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal‐related relapse
Abstract
Objective: To examine the evidence that discontinuation of long‐term antipsychotic medication, including clozapine, may provoke a psychotic episode. Method: Databases were searched and citations scrutinised. Results: Evidence for a rapid onset psychosis (supersensitivity psychosis) following clozapine withdrawal was found and weaker evidence that this might occur with some other antipsychotic drugs. Some cases were reported in people without a psychiatric history. It appears that the psychosis may be a feature of drug withdrawal rather than the re‐emergence of an underlying illness, at least in some patients. Meta‐analyses of withdrawal studies have suggested that antipsychotic discontinuation may also increase the risk of relapse over and above the risk because of the underlying disorder, but not all individual studies show this effect. Mechanisms may relate to brain adaptations to long‐term drug use but data are sparse. Conclusion: These effects require further urgent research. Interventions to reduce morbidity after drug withdrawal need to be developed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ketamine (intravenous anesthetic) and esketamine (nasal spray) potentially produce psychological dependence and rapidly induce pharmacological tolerance [136-139].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [137]
Citations
Cites
Neuroleptic Withdrawal in Schizophrenic Patients
Gilbert, P. L. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950150005001 · Cited by 434
Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder
Suppes, T. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810360046007 · Cited by 392
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Silvestri, S., Seeman, M. V., Negrete, J.-C., Houle, S., Shammi, C. M., Remington, G. J., Kapur, S., Zipursky, R. B., Wilson, A. A., Christensen, B. K., et al. (2000) · Psychopharmacology · doi:10.1007/s002130000532 · Cited by 311
Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics
(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.1.16 · Cited by 301
Dopaminergic supersensitivity after neuroleptics: time-course and specificity
Muller, P., & Seeman, P. (1978) · Psychopharmacology · doi:10.1007/bf00429171 · Cited by 271
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment
Viguera, A. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130055011 · Cited by 246 · cited 7×
“Dopamine receptor supersensitivity has been suggested as one such possible adaptation (48).”
BackgroundInfluentialSeeman, P., & Tallerico, T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.876 · Cited by 237
Gitlin, M. J., Nuechterlein, K. H., Subotnik, K. L., Ventura, J., Mintz, J., Fogelson, D. L., Bartzokis, G., & Aravagiri, M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1835 · Cited by 216
Neuroleptic Withdrawal in Schizophrenic Patients
Baldessarini, R. J. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950150021002 · Cited by 194
Flagged first, then by citations
2 of the 64 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Franks MA, 2005, The consequences of suddenly stopping psychotropic medication in bipolar disorder, Bipolar Disorders, 4, 11
- 10.1345/aph.1A440 · DOI · Paper page
Cited by
Sorted by citations
Items 101–200 of 231
Continuity of supply of psychiatric medicines for newly received prisoners
Hassan, L., Senior, J., Edge, D., & Shaw, J. J. (2011) · The Psychiatrist · doi:10.1192/pb.bp.110.031757 · Cited by 15
Kanahara, N., Kimura, H., Oda, Y., Ito, F., & Iyo, M. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210125152815 · Cited by 13
Kimura, H., Kanahara, N., & Iyo, M. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113126 · Cited by 16
Long-Acting Injectable Risperidone and Hospital Readmission
Chang, H.-C., Tang, C., Tsai, S., Yen, F.-C., & Su, K. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08l04447 · Cited by 14
Symptoms of schizophrenia: Normal adaptations to inability
Seeman, M. V. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.12.028 · Cited by 14
The pharmacological treatment of schizophrenia: how far have we come?
Rubio, J. M., & Kane, J. M. (2022) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.13 · Cited by 13
“91 These theories have been hypothesized because of antipsychotic withdrawal, which would result in rebound psychosis, 92 but this theory has not been validated by either clinical research of abrupt versus progressive treatment discontinuation, 88 nor neurobiological research on dopamine receptor…”
BackgroundNon-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review
Yee, B., Looi, J. C., Agaciak, M., Allison, S. C., Chan, S. K. W., & Bastiampillai, T. J. (2023) · East Asian Archives of Psychiatry · doi:10.12809/eaap2261 · Cited by 13
Olanzapine withdrawal/discontinuation-induced hyperthermia in rats
Goudie, A. J., Cole, J. C., & Sumnall, H. R. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.007 · Cited by 13
Ballesteros, A., Torres, A. S. S., López-Ilundain, J., Mezquida, G., Lobo, A., González-Pinto, A., Pina-Camacho, L., Corripio, I., Vieta, E., de la Serna, E., et al. (2020) · Psychological Medicine · doi:10.1017/s003329172000080x · Cited by 9
Confounding of Antipsychotic Discontinuation Studies by Withdrawal-Related Relapse
Horowitz, M. A., Murray, R. M., & Taylor, D. M. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab146 · Cited by 12
Using Crisis Theory in Dealing With Severe Mental Illness–A Step Toward Normalization?
Baumgardt, J., & Weinmann, S. (2022) · Frontiers in Sociology · doi:10.3389/fsoc.2022.805604 · Cited by 19
Bressington, D. T., & White, J. (2015) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12249 · Cited by 14
Towards a framework to develop neuroimaging biomarkers of relapse in schizophrenia
Rubio, J. M., Malhotra, A. K., & Kane, J. M. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113099 · Cited by 13
Should we be ‘pushing meds’? The implications of pharmacogenomics
Bray, J., CLARKE, C., Brennan, G., & Muncey, T. (2008) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/j.1365-2850.2007.01234.x · Cited by 12
Sacchetti, E., & Vita, A. (2013) · Springer eBooks · doi:10.1007/978-88-470-2679-7_1 · Cited by 11
Oda, Y., Fujita, Y., Oishi, K., Nakata, Y., Takase, M., Niitsu, T., Kanahara, N., Shirayama, Y., Hashimoto, K., & Iyo, M. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4695-5 · Cited by 11
Shaker, A., & Jones, R. (2017) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125317741449 · Cited by 11
Larsen-Barr, M., & Seymour, F. W. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125321989133 · Cited by 11
Salomon, C., & Hamilton, B. E. (2012) · International Journal of Mental Health Nursing · doi:10.1111/j.1447-0349.2012.00889.x · Cited by 11
Kanahara, N., Oda, Y., Kimura, H., Watanabe, H., Hashimoto, K., & Iyo, M. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s86042 · Cited by 12
Rafizadeh, R., Frankow, L., Mahmood, H., Poonia, S., Mathew, N., Danilewitz, M., Bousman, C., Honer, W. G., & Schütz, C. G. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231191781 · Cited by 10
Domperidone as an unintended antipsychotic
Ferrier, J. (2014) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163514521969 · Cited by 10
Early psychotic experiences: Interventions, problems and perspectives.
Dimitrakopoulos, S., Kollias, C. T., Stefanis, N. C., & Kontaxakis, V. P. (2015) · PubMed · Cited by 10
A Critical Perspective on the Role of Psychotropic Medications in Mental Health Courts
Hughes, S., & Peak, T. (2013) · American Behavioral Scientist · doi:10.1177/0002764212458273 · Cited by 9
Clozapine withdrawal malignant catatonia in a medical intensive care unit setting
Brailey, J., & Bastiampillai, T. J. (2020) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.102043 · Cited by 9
Effects of repeated electroconvulsive shocks on dopamine supersensitivity psychosis model rats
Kimura, M., Oda, Y., Oishi, K., Yoshino, K., Kimura, H., Niitsu, T., Kanahara, N., Shirayama, Y., Hashimoto, K., & Iyo, M. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.11.062 · Cited by 9
Managing clozapine discontinuation – acute and chronic maintenance strategies
Shields, M. K., Bastiampillai, T. J., & Mohan, T. S. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867411432215 · Cited by 9
Pharmacological strategies for relapse prevention in schizophrenia
Barnes, T. R. E., & Drake, R. (2007) · Psychiatry · doi:10.1016/j.mppsy.2007.07.002 · Cited by 9
Aripiprazole-Induced Agitation After Clozapine Discontinuation
Cho, D. Y., & Lindenmayer, J. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08l04528 · Cited by 9
Helping people to discontinue antipsychotics: if, when and how
Moncrieff, J., & Horowitz, M. A. (2025) · Schizophrenia · doi:10.1038/s41537-025-00695-x · Cited by 9
Self-citationKimura, M., Oda, Y., Hirose, Y., Kimura, H., Yoshino, K., Niitsu, T., Kanahara, N., Shirayama, Y., Hashimoto, K., & Iyo, M. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173288 · Cited by 8
Psychosis Related to Baclofen Withdrawal or Overdose: A Systematic Review
Phu, P. J. J., Looi, J. C., Nair, P. C., Allison, S. C., Chan, S. K. W., & Bastiampillai, T. J. (2023) · East Asian Archives of Psychiatry · doi:10.12809/eaap2237 · Cited by 8
Perspective on medication decisions following remission from first-episode psychosis
Hui, C. L. M., Lam, B. S. T., Lee, E. H. M., Chan, S. K. W., Chang, W. C., Suen, Y. N., & Chen, E. Y. H. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.02.007 · Cited by 10
King, S. R., Allan, M., & Lindsey, L. (2022) · Psychosis · doi:10.1080/17522439.2022.2141841 · Cited by 8
Tibrewal, P., Nair, P. C., Gregory, K. J., LANGMEAD, C. J., Chan, S. K. W., & Bastiampillai, T. J. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02026-x · Cited by 8
Schizophrenia and Related Psychoses
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg001 · Cited by 9
Ostuzzi, G., & Barbui, C. (2015) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015000980 · Cited by 5
Zheng, H., Jiang, X., Yang, R., Wang, S., & Zhong, H. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1079456 · Cited by 6
Enjeux cliniques du passage d’un antipsychotique à l’autre
Constant, É. (2013) · L Encéphale · doi:10.1016/j.encep.2013.10.001 · Cited by 6
Roiter, B., Pigato, G., & Perugi, G. (2016) · Case Reports in Psychiatry · doi:10.1155/2016/1393982 · Cited by 5
Yamasaki, F., Kanahara, N., Nakata, Y., Koyoshi, S., Yanagisawa, Y., Saito, T., Oiwa, T., Kogure, M., Sasaki, T. G., Yoshida, T., et al. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231177268 · Cited by 6
Challenges in pharmacologic management of the hospitalized patient with psychiatric comorbidity
Ward, M., & Schwartz, A. C. (2013) · Journal of Hospital Medicine · doi:10.1002/jhm.2059 · Cited by 5
Sanders, P. (2007) · Person-Centered & Experiential Psychotherapies · doi:10.1080/14779757.2007.9688435 · Cited by 5
Switch-associated adverse events: focus on olanzapine
Xu, L., & Krishnaswamy, S. (2018) · Australasian Psychiatry · doi:10.1177/1039856218810166 · Cited by 5
Accinni, T., Frascarelli, M., Ghezzi, F., Panzera, A., Buzzanca, A., Fanella, M., Bonaventura, C. D., Carlone, L., Girardi, N., Pasquini, M., et al. (2021) · Clinical Case Reports · doi:10.1002/ccr3.4134 · Cited by 5
Ostinelli, E. G., Cavallotti, S., Fanti, V., Demartini, B., Gambini, O., & D’Agostino, A. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12899 · Cited by 5
Deconstructing psychiatric drug treatment
Moncrieff, J. (2009) · doi:10.1007/978-1-349-92322-9_47 · Cited by 5
Self-citationClozapine and anti-cancer agents: a systematic literature review of case reports
Honor, A., Parmenter, J., Marsh, R., Siskind, D. J., & Warren, N. (2025) · CNS Spectrums · doi:10.1017/s1092852925100576 · Cited by 4
Ma, C.-H., Chan, H., Hsieh, M. H., Liu, C., Liu, C., Hwu, H., Kuo, C., Chen, W. J., & Hwang, T. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211064396 · Cited by 4
Amha, H., Getnet, A., Munie, B. M., Workie, T., Alem, G., Mulugeta, H., Bishaw, K. A., Ayenew, T., Gedfew, M., Desta, M., et al. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01900-1 · Cited by 4
Martínez-Granados, F., Briones‐Vozmediano, E., & Ronda, E. (2024) · Salud Colectiva · doi:10.18294/sc.2024.5090 · Cited by 4
Metoclopramide-induced rapid-onset psychosis in a child with methylphenidate use: a case report
Ekici, G. İ., Dinç, G. Ş., & Kurt, A. N. Ç. (2024) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2024.5319 · Cited by 4
Reconnaître les symptômes psychiatriques iatrogènes liés aux antipsychotiques
Demily, C., Chouinard, V., & Chouinard, G. (2010) · L Encéphale · doi:10.1016/j.encep.2010.01.003 · Cited by 4
Excesos y alternativas de la salud mental en atención primaria
Lobo, A. O., & Bernstein, J. (2015) · Revista Brasileira de Medicina de Família e Comunidade · doi:10.5712/rbmfc10(35)1055 · Cited by 4
Assessing the Effects of Antipsychotics on Parenting
Seeman, M. V. (2017) · Women’s Health Bulletin · doi:10.5812/whb.13409 · Cited by 4
Deprescribing and Its Application to Psychiatry
Gupta, S., & Miller, R. A. (2018) · Springer eBooks · doi:10.1007/978-3-030-02732-2_6 · Cited by 4
Kobayashi, R., Oda, Y., Hayatsu, R., Ohki, N., Akutsu, M., Oiwa, T., Komatsu, H., Niitsu, T., Sasaki, T. G., & Iyo, M. (2020) · SAGE Open Medical Case Reports · doi:10.1177/2050313x20929561 · Cited by 4
Compounding the trauma: the coercive treatment of voice hearers
Sapey, B. (2012) · European Journal of Social Work · doi:10.1080/13691457.2012.674490 · Cited by 4
De novo treatment-resistant psychosis following thioridazine withdrawal
Bastiampillai, T. J., Fantasia, R., & Nelson, A. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413499943 · Cited by 4
Adverse Effects of Antipsychotics
Landry, P., Rousseau, A., & Skalli, L. (2010) · Wiley eBooks · doi:10.1002/9780470749180.ch17 · Cited by 5
Should denialism of mental illness and its treatment be included among conspiracy theories?
Fountoulakis, K. Ν. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01272-w · Cited by 4
Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone
Jacob, M. K., Ash, P., & Craighead, W. E. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0239-z · Cited by 3
Ethical Considerations in Global Mental Health Research
Loue, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-66296-7_4 · Cited by 3
Selbsttäuschungen in der Psychiatrie
Weinmann, S. (2021) · Kontext · doi:10.13109/kont.2021.52.2.127 · Cited by 3
Fountoulakis, K. Ν. (2021) · Springer eBooks · doi:10.1007/978-3-030-86541-2_25 · Cited by 3
Read, J. (2024) · Psychology and Psychotherapy Theory Research and Practice · doi:10.1111/papt.12551 · Cited by 3
Aggressive behaviour in schizophrenic patients after abrupt treatment discontinuation
Kapsali, F., Rabavilas, A. D., Michopoulou, A., Papadimitriou, G. N., & Papageorgiou, C. (2011) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2011.589517 · Cited by 3
Towards personalized pharmacology: Antipsychotics and schizophrenia
Carton, L., Bordet, R., Montastruc, F., & Guilhaumou, R. (2020) · Therapies · doi:10.1016/j.therap.2020.12.010 · Cited by 4
Activation Induced by High-Dose Ziprasidone
Kaushik, S., Maccabee, N., Kaushik, S., & Lindenmayer, J. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08l04400 · Cited by 3
Should the Clozapine Protocol be Obeyed?
DREW, L. R. H. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.587398 · Cited by 3
Cohen, D. (2007) · Journal of College Student Psychotherapy · doi:10.1300/j035v21n03_09 · Cited by 3
Kimura, M., Oda, Y., Kimura, H., Nangaku, M., Hirose, Y., Niitsu, T., Kanahara, N., Shirayama, Y., Hashimoto, K., & Iyo, M. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173114 · Cited by 3
ACKR1 genetic testing should be offered before starting clozapine treatment
Murtough, S., Mills, D., Khani, N. S., Cotic, M., Varney, L., Richards‐Belle, A., Abidoph, R., Bass, N. J., Chauhan, D., Curran, S. R., et al. (2026) · Nature Mental Health · doi:10.1038/s44220-025-00554-9 · Cited by 2
Wang, G., Thakoor, J. P. D., Wang, X., & Hao, W. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000061 · Cited by 2
Suicidality and psychotic episodes after starting aripiprazole: two case reports
Meyer, G., Faria, C. G. F., Beck, M., Riutort, M., Michel, B., & Javelot, H. (2022) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000408 · Cited by 2
Tasch, G., & Gøtzsche, P. C. (2023) · Psychosis · doi:10.1080/17522439.2023.2183428 · Cited by 2
An Unusual Cause of Delirium in a Psychiatric Patient: Abrupt Clozapine Discontinuation
Wong, O., Fung, H., & Lam, T. (2010) · Hong Kong Journal of Emergency Medicine · doi:10.1177/102490791001700210 · Cited by 2
Amisülpirid Kesilmesini İzleyen Okülerjik Krizin Eşlik Ettiği Psikotik Alevlenme: Olgu Sunumu
Özcan, S., Tamam, L., & Soydan, A. (2013) · Nöro Psikiyatri Arşivi · doi:10.4274/npa.y6411 · Cited by 2
Catastrophic Complications Related to Psychopharmacologic Drug Withdrawal
Jenkins, J., & Glass, S. P. (2016) · Psychiatric Annals · doi:10.3928/00485713-20160621-01 · Cited by 2
Fountoulakis, K. Ν., Panagiotidis, P., & Nimatoudis, I. (2019) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2712 · Cited by 2
Feeney, L. (2009) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.108.006353 · Cited by 2
Principles of Pharmacological Treatment in Schizophrenia
Barnes, T. R. E., & Marder, S. R. (2010) · doi:10.1002/9781444327298.ch24 · Cited by 2
Supersensitivity psychosis and aripiprazole tapering
Pae, C. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.03.028 · Cited by 2
Thompson, A. D., Marwaha, S., & Broome, M. R. (2016) · BJPsych Advances · doi:10.1192/s2056467800002838 · Cited by 1
Low-Dose Lithium for Long-Term Treatment of Clozapine- Induced Neutropenia: A Case Series
Baig, M. R. (2019) · Current Psychopharmacologye · doi:10.2174/2211556008666190130165540 · Cited by 1
Deprescribing Antipsychotic Medications
Gupta, S., Miller, R. A., & Cahill, J. D. (2019) · doi:10.1093/med/9780190654818.003.0009 · Cited by 1
Tuffour, I. (2021) · Nursing Inquiry · doi:10.1111/nin.12484 · Cited by 1
Clozapine in the Treatment of Psychosis
Laux, G. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_472 · Cited by 1
Clinical challenges in the dosing and titration of cariprazine
Miljević, Č., Vuković, P. G., & Munjiza, A. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1427482 · Cited by 1
Barteček, R., Kašpárek, T., & Češková, E. (2011) · Open Medicine · doi:10.2478/s11536-011-0055-8 · Cited by 1
Clozapine induced neutropenia, onset after 6 years of treatment: a case report
Bullock, S. A., & Bescoby-Chambers, N. J. C. (2019) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000287 · Cited by 1
La schizophrénie n’est pas une maladie
Sanders, P., & Berthoud, L. (2019) · Approche Centrée sur la Personne Pratique et recherche · doi:10.3917/acp.027.0063 · Cited by 1
Fedotova, J. (2020) · The Open Biology Journal · doi:10.2174/1874196702008010029 · Cited by 1
Rapid-Onset Psychosis and Cholinergic Rebound After Abrupt Discontinuation of Clozapine
Palkar, P., Garces, E., Chavali, S., Zubair, A. S., & Hashmi, S. (2021) · Psychiatric Annals · doi:10.3928/00485713-20210105-01 · Cited by 1
Bentall, R. P., & Morrison, P. T. (2011) · Psychosis · doi:10.1080/17522439.2011.577588 · Cited by 1
Stewart, G. D., Sexton, P. M., & Christopoulos, A. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_297 · Cited by 1
Schizophrenia and Related Psychoses
(2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg001.pub2 · Cited by 2
Onset, course and comorbidity of bipolar symptoms in population and treatment settings
Rossum, I. W.-V. (2010) · Research Publications (Maastricht University) · doi:10.26481/dis.20100114ir
Cognitieve gedragstherapie bij jongeren met risicosymptomen voor een psychose
Nieman, D. H., Becker, H. E., Gevers, C., & LINSZEN, D. H. (2007) · Kind & Adolescent Praktijk · doi:10.1007/bf03059619
Kimura, H., Kanahara, N., Komatsu, N., Ishige, M., Muneoka, K. T., Yoshimura, M., Yamanaka, H., Suzuki, T., Komatsu, H., Sekine, Y., et al. (2013) · European Psychiatry · doi:10.1016/s0924-9338(13)77342-5
Metadata
- Authors
- Moncrieff, J.
- Affiliations
- University College London (GB)
- Corresponding author
- Moncrieff, J.
- ORCID
- Moncrieff, J.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2006-03-23
- Volume
- 114
- Issue
- 1
- Pages
- 3-13
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2168608597
- Cited by
- 231
- References
- 64
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 8 · 2022: 10 · 2021: 23 · 2020: 14 · 2019: 13 · 2018: 10 · 2017: 8 · 2016: 18 · 2015: 19 · 2014: 13 · 2013: 14 · 2012: 11
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Acta Psychiatrica Scandinavica (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- antipsychotic withdrawal, clozapine, antipsychotic discontinuation, psychosis relapse, drug withdrawal
- MeSH terms
- Clozapine, Humans, Long-Term Care, Psychoses, Substance-Induced, Psychotic Disorders, Recurrence, Risk Factors, Substance Withdrawal Syndrome, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review